HEALTH REFORM'S EFFECT ON CANCER THERAPY INNOVATION
This article was originally published in The Gray Sheet
Executive SummaryHEALTH REFORM'S EFFECT ON CANCER THERAPY INNOVATION will be addressed at a Feb. 2 hearing of the House Science/Technology Sub- committee, chaired by Rep. Tim Valentine (D-N.C.). The heating "will focus on the possible impacts of health care reform on U.S. efforts to develop better techniques for diagnosing, controlling, and curing cancer," and will use cancer as a case study for assessing technological innovation in general, according to subcommittee background literature.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.